EcoR1 Capital, LLC
Q1 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
46
- Value ($000)
$1,686,023
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001587114
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $260.16M | 15 % | 11,895,808 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $211.86M | 13 % | 1,706,469 | ||
ZYME ZYMEWORKS INC | COM | 98985Y108 | $205.56M | 12 % | 17,259,548 | ||
ANAB ANAPTYSBIO INC | COM | 032724106 | $146.49M | 9 % | 7,880,094 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $143.82M | 9 % | 4,288,120 | ||
PROTHENA CORP PLC | SHS | G72800108 | $143.36M | 9 % | 11,584,280 | ||
SRPT SAREPTA THERAPEUTICS INC | COM | 803607100 | $82.48M | 5 % | 1,292,386 | ||
XNCR XENCOR INC | COM | 98401F105 | $65.38M | 4 % | 6,144,767 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $47.28M | 3 % | 1,389,276 | ||
UNIQURE NV | SHS | N90064101 | $42.28M | 3 % | 3,988,971 |
Rows Per Page
10
- 10
- 50
- 100